BioCardia, Inc. (BCDA)

NASDAQ: BCDA · IEX Real-Time Price · USD
+0.02 (0.98%)
At close: Mar 24, 2023, 4:00 PM
+0.02 (0.97%)
After-hours: Mar 24, 2023, 4:00 PM EDT

Total Valuation

BioCardia has a market cap or net worth of $41.69 million. The enterprise value is $36.73 million.

Market Cap 41.69M
Enterprise Value 36.73M

Important Dates

The next earnings date is Tuesday, May 9, 2023, after market close.

Estimated Earnings Date May 9, 2023
Ex-Dividend Date n/a

Share Statistics

BioCardia has 20.05 million shares outstanding. The number of shares has increased by 4.56% in one year.

Shares Outstanding 20.05M
Shares Change (YoY) +4.56%
Shares Change (QoQ) +1.09%
Owned by Insiders (%) 33.25%
Owned by Institutions (%) 17.96%
Float 11.29M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 31.47
Forward PS 1,135.47
PB Ratio 10.18
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 27.72
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.42.

Current Ratio 1.94
Quick Ratio 1.89
Debt / Equity 0.42
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -172.70% and return on invested capital (ROIC) is -1,321.20%.

Return on Equity (ROE) -172.70%
Return on Assets (ROA) -100.70%
Return on Capital (ROIC) -1,321.20%
Revenue Per Employee $47,321
Profits Per Employee -$440,714
Employee Count 28
Asset Turnover 0.11
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.09% in the last 52 weeks. The beta is 1.07, so BioCardia's price volatility has been similar to the market average.

Beta (1Y) 1.07
52-Week Price Change -2.09%
50-Day Moving Average 2.22
200-Day Moving Average 1.90
Average Volume (30 Days) 31,111

Short Selling Information

The latest short interest is 37,538, so 0.19% of the outstanding shares have been sold short.

Short Interest 37,538
Short Previous Month 35,811
Short % of Shares Out 0.19%
Short % of Float 0.33%
Short Ratio (days to cover) 1.58

Income Statement

In the last 12 months, BioCardia had revenue of $1.33 million and -$12.34 million in losses. Loss per share was -$0.71.

Revenue 1.33M
Gross Profit 1.33M
Operating Income -12.34M
Pretax Income -12.34M
Net Income -12.34M
EBITDA -12.46M
EBIT -12.34M
Loss Per Share -$0.71
Full Income Statement

Balance Sheet

The company has $6.67 million in cash and $1.70 million in debt, giving a net cash position of $4.97 million or $0.25 per share.

Cash & Cash Equivalents 6.67M
Total Debt 1.70M
Net Cash 4.97M
Net Cash Per Share $0.25
Equity / Book Value 4.10M
Book Value Per Share 0.20
Working Capital 3.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.54 million and capital expenditures -$109,000, giving a free cash flow of -$10.65 million.

Operating Cash Flow -10.54M
Capital Expenditures -109,000
Free Cash Flow -10.65M
FCF Per Share -$0.60
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -931.62% and -931.32%.

Gross Margin 100.00%
Operating Margin -931.62%
Pretax Margin -931.32%
Profit Margin -931.32%
EBITDA Margin -940.60%
EBIT Margin -931.32%
FCF Margin -803.62%

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -29.60%
FCF Yield -25.54%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -4.56%
Shareholder Yield -4.56%
Dividend Details

Analyst Forecast

The average price target for BioCardia is $7.65, which is 271.36% higher than the current price. The consensus rating is "Buy".

Price Target $7.65
Price Target Difference 271.36%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 73.13%
EPS Growth Forecast (5Y) -12.06%
Stock Forecasts

Stock Splits

The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.

Last Split Date Jun 6, 2019
Split Type Reverse
Split Ratio 1:9